VivoSeq
Other

Ablation

0

Pipeline Programs↗

3

Active Trials↗

5

Companies Involved↗

Ablation is an early-stage landscape with 0 programs across 5 companies. The most active players are TR Therapeutics, Boehringer Ingelheim, Sanofi.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

10/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

T

TR Therapeutics

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

PreclinicalP

Provectus Biopharmaceuticals, Inc.

0 programs

PreclinicalBayer logo

Bayer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

29

clinical trials

Completed17 · 59%
Unknown status6 · 21%
Terminated3 · 10%
Active, not recruiting1 · 3%
Not yet recruiting1 · 3%
Recruiting1 · 3%

Clinical Trials

Trial Activity

29 trials

Peking University People's Hospital Breast Surgery Department
Recruiting·PPeking University People's Hospital·Preclinical·NCT07238894·200 enrolled
Evaluation of PET/MR in Patients Selected for Ablation Therapy
Active, not recruiting·MMassachusetts General Hospital·Phase 2·NCT03265431·34 enrolled
Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC
Not yet recruiting·HHuashan Hospital·N/A·NCT06324058·190 enrolled
Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCC
Completed·SSun Yat-sen University·Phase 2·NCT03939975·50 enrolled
Contrast ICE for Myocardial Scar in VT Ablations
Completed·WWeill Medical College of Cornell University·N/A·NCT03212326·24 enrolled
Butorphanol in Pain Following Ablation for Hepatic Tumor
Completed·—·N/A·NCT06031129·300 enrolled
Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 4·NCT02348723·678 enrolled
Imaging With a Radio Tracer to Guide VT Ablations
Completed·UUniversity of Maryland, Baltimore·N/A·NCT01250912·20 enrolled
Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies
Completed·MM.D. Anderson Cancer Center·Phase 2·NCT01254864·190 enrolled
Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation
Completed·TTR Therapeutics·Phase 2·NCT00792688·26 enrolled
The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin Cream
Completed·MMayo Clinic·Phase 1·NCT01883102·1 enrolled
Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints
Completed·DDefense and Veterans Center for Integrative Pain Management·Phase 4·NCT02571634·23 enrolled
Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC
Completed·IInstitute of Liver and Biliary Sciences, India·N/A·NCT05068076·21 enrolled
Ganglionated Plexi Ablation vs Renal Denervation in Patients Undergoing Pulmonary Vein Isolation
Completed·MMeshalkin Research Institute of Pathology of Circulation·Phase 2·NCT01898910·80 enrolled
Laser Ablation Versus Mechanochemical Ablation Trial
Completed·HHull University Teaching Hospitals NHS Trust·Phase 4·NCT02627846·150 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)